
In vitro anti-osteoclastogenic activity of p38 inhibitor doramapimod via inhibiting migration of pre-osteoclasts and NFATc1 activity
Keywords: Doramapimod; p38 inhibitor; Osteoclast differentiation; Migration; Fusion